Albert David Quarterly Results for Trading Insights
ALBERTDAVD • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹17 Cr
QMarch 2025
Albert David Quarterly Results Key Highlights
- Revenue of ₹375 Cr in March 2025 (+0.0% vs March 2025, -10.7% vs March 2024)
- Net Profit of ₹17 Cr in March 2025 (+0.0% vs March 2025, -77.3% vs March 2024)
- EBITDA of ₹33 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 1.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹30.14 in March 2025 (+0.0% vs March 2025)
Albert David Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 322 | 375 | 420 | 357 | 329 | -14.1% | - |
| Net Profit (₹ Cr) | -15 | 17 | 75 | 36 | 35 | - | - |
| EBITDA (₹ Cr) | -6 | 33 | 104 | 60 | 57 | - | - |
| EPS (₹) | -26.40 | 30.14 | 132.15 | 63.39 | 61.78 | - | - |
| Operating Margin (%) | -4.0% | 1.0% | 13.0% | 13.0% | 13.0% | - | - |
Albert David Share Price Trend Around Quarterly Results
Visualize Albert David's 1-year price movement across quarterly results — ideal for logging trades in Albert David share price
chart using Tickjournal. All values in ₹.
Related Pages for Albert David
Additional stock information and data for ALBERTDAVD
Revenue Trend (₹ Cr)
March 2023
357
March 2024
420
March 2025
375
2026
322
Net Profit Trend (₹ Cr)
March 2023
36
March 2024
75
March 2025
17
2026
-15
Operating Margin Trend (%)
March 2023
13.0%
March 2024
13.0%
March 2025
1.0%
2026
-4.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Albert David quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹409,614.47 Cr | 1704.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.1 |
|
Divis Laboratories
Sept 2025 |
₹159,931.55 Cr | 6113.5 | 2,860 | 689 | +7.1% | - | 24.1% | 235.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹133,313.66 Cr | 3997.2 | 3,219 | 591 | +11.3% | - | 18.4% | 227.9 |
|
Cipla
Sept 2025 |
₹107,433.65 Cr | 1342.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.2 |
|
Dr Reddys Laborator…
Sept 2025 |
₹106,457.10 Cr | 1275.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 78.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores